Oncology

Takeda
Biotech

Takeda inks $1.7B AI discovery deal with Iambic Therapeutics

The project aims to advance certain Takeda small molecules, with the work starting in the oncology, gastrointestinal and inflammation treatment areas.
Will Maddox Feb 9, 2026 8:00am
A ballpoint pen rests on top of a stack of documents ready for signing

Lilly, Innovent pen $8.8B collab 'beyond traditional licensing'

Feb 9, 2026 6:45am
IPO initial public offering Wall Street

Eikon upsized $381M listing marks largest biotech IPO since 2024

Feb 5, 2026 4:23am
Red and white pawns with golden arrows Employee swap or turnover concept

Moderna's latest CMO steps down after barely a year

Jan 30, 2026 10:58am
money funding financing bank

Eikon sets $274M goal for upcoming stock market debut

Jan 28, 2026 2:00pm
craft scissors glue paper glue stick

Fortitude has faith glue degraders can beat ADC resistance

Jan 26, 2026 10:47am
More News

Cancer imaging company buys Lisata for ph. 2-stage tumor drug

Jan 21, 2026 9:20am

Worldwide Clinical Trials adds Catalyst to global CRO mixture

Jan 20, 2026 2:54pm

JPM26: Gilead eyes new deals from a 'position of strength'

Jan 14, 2026 3:30am

Eikon plans IPO to bankroll clutch of clinical cancer drugs

Jan 12, 2026 4:40am